S&P 500   5,072.96 (-0.10%)
DOW   38,900.85 (-0.18%)
QQQ   436.45 (-0.26%)
AAPL   181.36 (-0.70%)
MSFT   407.46 (+0.00%)
META   487.18 (+0.03%)
GOOGL   135.89 (-2.15%)
AMZN   173.81 (+0.16%)
TSLA   204.14 (+2.21%)
NVDA   785.71 (-0.17%)
NIO   5.54 (-4.15%)
AMD   176.02 (-1.11%)
BABA   75.32 (-3.04%)
T   17.04 (+1.25%)
F   12.32 (+2.67%)
MU   89.76 (-2.28%)
CGC   3.50 (-0.85%)
GE   155.23 (+0.81%)
DIS   110.80 (+1.26%)
AMC   5.02 (+4.37%)
PFE   27.09 (+0.74%)
PYPL   60.89 (+1.21%)
XOM   104.35 (+0.31%)
S&P 500   5,072.96 (-0.10%)
DOW   38,900.85 (-0.18%)
QQQ   436.45 (-0.26%)
AAPL   181.36 (-0.70%)
MSFT   407.46 (+0.00%)
META   487.18 (+0.03%)
GOOGL   135.89 (-2.15%)
AMZN   173.81 (+0.16%)
TSLA   204.14 (+2.21%)
NVDA   785.71 (-0.17%)
NIO   5.54 (-4.15%)
AMD   176.02 (-1.11%)
BABA   75.32 (-3.04%)
T   17.04 (+1.25%)
F   12.32 (+2.67%)
MU   89.76 (-2.28%)
CGC   3.50 (-0.85%)
GE   155.23 (+0.81%)
DIS   110.80 (+1.26%)
AMC   5.02 (+4.37%)
PFE   27.09 (+0.74%)
PYPL   60.89 (+1.21%)
XOM   104.35 (+0.31%)
S&P 500   5,072.96 (-0.10%)
DOW   38,900.85 (-0.18%)
QQQ   436.45 (-0.26%)
AAPL   181.36 (-0.70%)
MSFT   407.46 (+0.00%)
META   487.18 (+0.03%)
GOOGL   135.89 (-2.15%)
AMZN   173.81 (+0.16%)
TSLA   204.14 (+2.21%)
NVDA   785.71 (-0.17%)
NIO   5.54 (-4.15%)
AMD   176.02 (-1.11%)
BABA   75.32 (-3.04%)
T   17.04 (+1.25%)
F   12.32 (+2.67%)
MU   89.76 (-2.28%)
CGC   3.50 (-0.85%)
GE   155.23 (+0.81%)
DIS   110.80 (+1.26%)
AMC   5.02 (+4.37%)
PFE   27.09 (+0.74%)
PYPL   60.89 (+1.21%)
XOM   104.35 (+0.31%)
S&P 500   5,072.96 (-0.10%)
DOW   38,900.85 (-0.18%)
QQQ   436.45 (-0.26%)
AAPL   181.36 (-0.70%)
MSFT   407.46 (+0.00%)
META   487.18 (+0.03%)
GOOGL   135.89 (-2.15%)
AMZN   173.81 (+0.16%)
TSLA   204.14 (+2.21%)
NVDA   785.71 (-0.17%)
NIO   5.54 (-4.15%)
AMD   176.02 (-1.11%)
BABA   75.32 (-3.04%)
T   17.04 (+1.25%)
F   12.32 (+2.67%)
MU   89.76 (-2.28%)
CGC   3.50 (-0.85%)
GE   155.23 (+0.81%)
DIS   110.80 (+1.26%)
AMC   5.02 (+4.37%)
PFE   27.09 (+0.74%)
PYPL   60.89 (+1.21%)
XOM   104.35 (+0.31%)

Outset Medical (OM) Competitors

$3.59
-0.20 (-5.28%)
(As of 12:03 PM ET)

OM vs. FONR, ELMD, EDAP, HYPR, MBTC, VANI, ECOR, SMLR, ZYXI, and AXGN

Should you be buying Outset Medical stock or one of its competitors? The main competitors of Outset Medical include FONAR (FONR), Electromed (ELMD), Edap Tms (EDAP), Hyperfine (HYPR), Nocturne Acquisition (MBTC), Vivani Medical (VANI), electroCore (ECOR), Semler Scientific (SMLR), Zynex (ZYXI), and AxoGen (AXGN). These companies are all part of the "electromedical equipment" industry.

Outset Medical vs.

Outset Medical (NASDAQ:OM) and FONAR (NASDAQ:FONR) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their risk, media sentiment, valuation, institutional ownership, earnings, dividends, community ranking, analyst recommendations and profitability.

FONAR received 149 more outperform votes than Outset Medical when rated by MarketBeat users. Likewise, 73.48% of users gave FONAR an outperform vote while only 35.71% of users gave Outset Medical an outperform vote.

CompanyUnderperformOutperform
Outset MedicalOutperform Votes
20
35.71%
Underperform Votes
36
64.29%
FONAROutperform Votes
169
73.48%
Underperform Votes
61
26.52%

Outset Medical has a beta of 2.05, meaning that its share price is 105% more volatile than the S&P 500. Comparatively, FONAR has a beta of 1.1, meaning that its share price is 10% more volatile than the S&P 500.

Outset Medical currently has a consensus target price of $5.13, indicating a potential upside of 35.22%. Given Outset Medical's higher probable upside, research analysts clearly believe Outset Medical is more favorable than FONAR.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Outset Medical
1 Sell rating(s)
3 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.00
FONAR
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A

46.1% of FONAR shares are held by institutional investors. 3.7% of Outset Medical shares are held by company insiders. Comparatively, 1.6% of FONAR shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

In the previous week, Outset Medical had 11 more articles in the media than FONAR. MarketBeat recorded 12 mentions for Outset Medical and 1 mentions for FONAR. FONAR's average media sentiment score of 0.00 beat Outset Medical's score of -0.20 indicating that FONAR is being referred to more favorably in the news media.

Company Overall Sentiment
Outset Medical Neutral
FONAR Neutral

FONAR has lower revenue, but higher earnings than Outset Medical. Outset Medical is trading at a lower price-to-earnings ratio than FONAR, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Outset Medical$130.38M1.47-$172.80M-$3.50-1.08
FONAR$98.64M1.48$9.38M$1.8412.52

FONAR has a net margin of 12.63% compared to Outset Medical's net margin of -132.54%. FONAR's return on equity of 8.47% beat Outset Medical's return on equity.

Company Net Margins Return on Equity Return on Assets
Outset Medical-132.54% -102.50% -52.42%
FONAR 12.63%8.47%6.45%

Summary

FONAR beats Outset Medical on 11 of the 17 factors compared between the two stocks.


Get Outset Medical News Delivered to You Automatically

Sign up to receive the latest news and ratings for OM and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding OM and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

OM vs. The Competition

MetricOutset MedicalElectromedical equipment IndustryMedical SectorNASDAQ Exchange
Market Cap$191.42M$3.14B$5.00B$7.50B
Dividend YieldN/A1.66%2.84%3.87%
P/E Ratio-1.0814.38267.0218.54
Price / Sales1.4772.763,363.94160.05
Price / CashN/A14.2925.7325.78
Price / Book1.553.894.694.64
Net Income-$172.80M$89.10M$112.29M$210.98M
7 Day Performance18.07%1.41%5.30%2.96%
1 Month Performance8.29%4.24%13.37%5.38%
1 Year Performance-83.38%49.30%13.45%8.21%

Outset Medical Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
FONR
FONAR
0 of 5 stars
$23.03
flat
N/A+35.7%$145.74M$102.42M12.52561High Trading Volume
ELMD
Electromed
0 of 5 stars
$15.05
+9.5%
N/A+11.2%$129.58M$48.07M33.45170Gap Up
High Trading Volume
EDAP
Edap Tms
2.1872 of 5 stars
$5.79
-4.8%
$13.67
+136.0%
-50.8%$213.71M$57.97M-9.34264Gap Down
HYPR
Hyperfine
1.4216 of 5 stars
$1.01
-9.0%
$2.38
+135.1%
-25.9%$72.32M$9.77M-1.53136High Trading Volume
MBTC
Nocturne Acquisition
0 of 5 stars
$11.70
-2.7%
N/A-2.6%$60.72MN/A0.002Upcoming Earnings
News Coverage
VANI
Vivani Medical
0.721 of 5 stars
$1.07
flat
N/A-1.9%$54.60MN/A-1.9150News Coverage
Positive News
Gap Up
ECOR
electroCore
2.4558 of 5 stars
$7.03
+1.7%
$10.00
+42.2%
+88.7%$42.18M$8.59M-1.6962Positive News
SMLR
Semler Scientific
0 of 5 stars
$47.80
-1.8%
N/A+110.2%$328.39M$56.69M19.12127Upcoming Earnings
News Coverage
ZYXI
Zynex
2.9904 of 5 stars
$12.59
-0.9%
$20.33
+61.5%
+7.1%$426.80M$158.17M29.28900Upcoming Earnings
AXGN
AxoGen
2.0303 of 5 stars
$10.42
-1.7%
$13.00
+24.8%
+28.1%$448.06M$138.58M-18.61394Upcoming Earnings
Analyst Upgrade

Related Companies and Tools

This page (NASDAQ:OM) was last updated on 2/28/2024 by MarketBeat.com Staff